henry-buchwald.jpg

13/06/19 - News

2019 Jacobson Innovation Award

Henry Buchwald receives ACS Jacobson Innovation Award 2019

The 2019 Jacobson Innovation Award of the American College of Surgeons (ACS) was presented to Dr Henry Buchwald, at a dinner held in his honour, by ACS President, Dr Ronald V Maier, for his life-long pioneering work and innovative research. The... (more)

glp-1_oral_semaglutide2.png

14/06/19 - News

Owen Haskins

PIONEER 6 trial

Oral semaglutide shows CV safety in T2DM patients

Novo Nordisk has announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide compared with placebo, both in addition to standard of care. PIONEER 6 was an event-driven, pre-... (more)

food.jpg

13/06/19 - News

Owen Haskins

Binge eating

People of a higher weight status more likely to binge eat

Binge eating is prevalent across socioeconomic status (SES) groups in the US and is linked to depressed mood, anxiety and obesity. A new study led by the University of Minnesota School of Public Health, explore the impact of several risk factors for binge eating among youth from... (more)

blood.jpg

12/06/19 - News

Owen Haskins

microRNA and T2DM

Using microRNA to detect early signs of type 2 diabetes in teens

Researchers know that exosomes, tiny nanoparticles released from fat cells, travel through the bloodstream and body, regulating a variety of processes, from growth and development to metabolism. The exosomes are important in lean, healthy individuals in maintaining homeostasis,... (more)

bone_fracture.png

Bariatric surgery and fracture risk

Study finds increased fracture risk after Roux-en-Y gastric bypass

10/06/19

Researchers from the Massachusetts General Hospital in Boston, MA, have reported that bariatric surgery is associated with health benefits,...

invokana.jpg

12/06/19 - News

Owen Haskins

CREDENCE analysis

Invokana reduces MACE and kidney failure in T2DM patients

The results of a new subgroup analysis from the landmark Phase III CREDENCE study shows Invokana (canagliflozin) significantly reduced the risk of major cardiovascular (CV) events and kidney failure in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD... (more)

obalon_touch.jpg

12/06/19 - News

Owen Haskins

Patent issued

Obalon issued first US Patent for Navigation System

Obalon Therapeutics has announces the issuance of US Patent No. 10,264,995, entitled ‘Systems and methods for locating and/or characterizing intragastric devices’. The first of its kind Obalon Navigation System provides the treating physician with the ability to place the Obalon... (more)

drugs.jpg

11/06/19 - News

Owen Haskins

ZGN-1061 outcomes

Zafgen presents results for ZGN-1061 from Phase 2 Clinical Trial

Zafgen has presented the full results of its Phase 2 clinical trial for ZGN-1061 in an oral presentation at the American Diabetes Association's 79th Scientific Sessions, as well as a poster on data demonstrating that treatment with ZGN-1061 improved measures of glycaemic control... (more)

More news

11/06/19 - Research

Revita DMR outcomes

Fractyl’s Revita DMR procedure has potential to end insulin injections

Fractyl Laboratories has presented interim data from the investigator-initiated INSPIRE clinical trial in collaboration with Fractyl showing Revita DMR, a same-day therapeutic procedure, can help eliminate the need for daily insulin injections for type 2 diabetes (T2D) patients. This data was... (more)

10/06/19 - Research

Bariatric surgery and fracture risk

Study finds increased fracture risk after Roux-en-Y gastric bypass

Researchers from the Massachusetts General Hospital in Boston, MA, have reported that bariatric surgery is associated with health benefits, however patients undergoing Roux-en-Y gastric bypass (RYGB) have an increased fracture risk and this should be considered when patients are in thinking of... (more)

10/06/19 - Research

Weight stigma

Inappropriate use of stigmatising terms in weight management

A large quantitative research study has found using the terms ‘weight’ or ‘high BMI (body mass index)’ to describe excess fatness was rated as less stigmatising and less blaming than commonly used medical terms, such as ‘fat’ or ‘obese’. The paper, ‘Dissonance in naming adiposity: a quantitative... (more)

07/06/19 - Research

Surgery, mortality and substance abuse

Bariatric surgery patients at higher risk of death from substance abuse

The death rate from drug- and alcohol-related causes in patients who have had Roux-en-Y gastric bypass surgery is nearly triple that of the general public, according to University of Pittsburgh researcher. The study also found that fewer than half of those who died had triggered a safety protocol... (more)

05/06/19 - Research

GBP and reflux

Effectiveness of gastric bypass on reflux symptoms overestimated

Although gastro‐oesophageal reflux symptoms do show a dramatic decline after gastric bypass surgery approximately half of patients required continuous anti‐reflux medication after surgery, according to researchers from Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. The... (more)

04/06/19 - Research

High body fat and mortality

High body fat not BMI linked to increase in mortality post-CAGB

Research presented at this year's Euroanaesthesia congress in Vienna, Austria, shows that mortality in patients who had undergone heart bypass surgery was over four times higher in individuals with a high body fat mass, while BMI by itself was not associated with an increase in mortality. The... (more)